1. Is Pfizer’s established drugs’ decline in China a canary in a coalmine? — Amgen biosimilar debut boosted by UnitedHealthcare coverage — Novartis CEO says FDA process could’ve been handled better — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

professional side

Discussion in 'Kimberly-Clark' started by Anonymous, Jul 9, 2014 at 3:31 PM.

  1. Anonymous

    Anonymous Guest

    How is the professional side doing these days? Is it a good place or the same as the healthcare side?
     
  2. Anonymous

    Anonymous Guest


    Great if you like working in the restrooms at Target, Costco, Wal Mart and asundry gas stations. Get a life, stay on the other side of the toilet stalls.
     
  3. Anonymous

    Anonymous Guest

    How's the pay for dealing with crap?